发明名称 Compositions and methods for inhibiting expression of the ALAS1 gene
摘要 The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ALAS1 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of ALAS1.
申请公布号 US9631193(B2) 申请公布日期 2017.04.25
申请号 US201314391392 申请日期 2013.04.10
申请人 ALNYLAM PHARMACEUTICALS, INC.;ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 发明人 Bettencourt Brian;Fitzgerald Kevin;Querbes William;Yasuda Makiko;Desnick Robert J.
分类号 C12N1/21;C12N15/113;A61K31/713 主分类号 C12N1/21
代理机构 Lando & Anastasi, LLP 代理人 Lando & Anastasi, LLP
主权项 1. A method of treating a disorder related to ALAS1 expression, comprising administering to a subject in need of such treatment a therapeutically effective amount of a double-stranded ribonucleic acid (dsRNA), wherein said dsRNA comprises a sense strand and an antisense strand, each of which are 15-30 nucleotides in length, wherein the antisense strand comprises a region of complementarity to an ALAS1 RNA and comprises at least 15 contiguous nucleotides differing by no more than 3 nucleotides from SEQ ID NO: 1296, and wherein the antisense strand is complementary to at least nucleotides 871-889 of SEQ ID NO: 1.
地址 Cambridge MA US